Search Results - "Rohr, U. P." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies

Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies

by Rohr, U.-P., Herrmann, P., Ilm, K., Zhang, H., Lohmann, S., Reiser, A., Muranyi, A., Smith, J., Burock, S., Osterland, M., Leith, K., Singh, S., Brunhoeber, P., Bowermaster, R., Tie, J., Christie, M., Wong, H.-L., Waring, P., Shanmugam, K., Gibbs, P., Stein, U.
Published in Annals of oncology (01.08.2017)

Get full text

Journal Article

Molecular signature of CD34 hematopoietic stem and progenitor cells of patients with CML in chronic phase

Molecular signature of CD34 hematopoietic stem and progenitor cells of patients with CML in chronic phase

by DIAZ-BLANCO, E, BRUNS, I, BAER, A, ROHR, U.-P, KOBBE, G, VON HAESELER, A, GATTERMANN, N, HAAS, R, KRONENWETT, R, NEUMANN, F, FISCHER, J. C, GRAEF, T, ROSSKOPF, M, BRORS, B, PECHTEL, S, BORK, S, KOCH, A
Published in Leukemia (01.03.2007)

Get full text

Journal Article

Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

by STEIDL, U, FENK, R, HAAS, R, KOBBE, G, BRUNS, I, NEUMANN, F, KONDAKCI, M, HOYER, B, GRÄF, T, ROHR, U-P, BORK, S, KRONENWETT, R
Published in Bone marrow transplantation (Basingstoke) (01.01.2005)

Get full text

Journal Article

The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

by Neukirchen, J, Meier, A, Rohrbeck, A, Garcia-Pardillos, G, Steidl, U, Fenk, R, Haas, R, Kronenwett, R, Rohr, U-P
Published in Cancer gene therapy (01.04.2007)

Get full text

Journal Article

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

by Fenk, R, Hoyer, B, Steidl, U, Kondakci, M, Graef, T, Heuk, R, Ruf, L, Strupp, C, Neumann, F, Rohr, U-P, Hildebrandt, B, Haas, R, Kobbe, G
Published in Leukemia (01.01.2005)

Get full text

Journal Article

1692MO Is project Orbis successful? The Swiss perspective

1692MO Is project Orbis successful? The Swiss perspective

by Pavic, M., Li, Q., Atiek, E., Wolfer, A., Rohr, U-P.
Published in Annals of oncology (01.10.2023)

Get full text

Journal Article

Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles

Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles

by Rohr, Ulrich-Peter, Heyd, Florian, Neukirchen, Judith, Wulf, Marc-Andre, Queitsch, Iris, Kroener-Lux, Gabriele, Steidl, Ulrich, Fenk, Roland, Haas, Rainer, Kronenwett, Ralf
Published in Journal of virological methods (01.07.2005)

Get full text

Journal Article

1349P A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products between Swissmedic, EMA and FDA

1349P A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products between Swissmedic, EMA and FDA

by Rohr, U-P., Iovino, M., Rudofsky, L., Li, Q., Juritz, S., Gircys, A., Wildner, O., Bujar, M., Dalla-Torre, S., Wolfer, A.
Published in Annals of oncology (01.09.2022)

Get full text

Journal Article

Early pain reduction in the treatment of spasticity after a single injection of botulinum A toxin

Early pain reduction in the treatment of spasticity after a single injection of botulinum A toxin

by Chalkiadaki, A, Rohr, U P, Hefter, H
Published in Deutsche medizinische Wochenschrift (30.11.2001)

Get more information

Journal Article

Inhibition of angiogenesis in vitro by αv integrin–directed antisense oligonucleotides

Inhibition of angiogenesis in vitro by αv integrin–directed antisense oligonucleotides

by Kronenwett, Ralf, Gräf, Thorsten, Nedbal, Wolfgang, Weber, Markus, Steidl, Ulrich, Rohr, Ulrich-Peter, Möhler, Thomas, Haas, Rainer
Published in Cancer gene therapy (01.07.2002)

Get full text

Journal Article

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector

by Rohr, Ulrich-Peter, Wulf, Marc-Andre, Stahn, Susanne, Heyd, Florian, Steidl, Ulrich, Fenk, Roland, Opalka, Bertram, Pitschke, Gerald, Prisack, Hans-Bernd, Bojar, Hans, Haas, Rainer, Kronenwett, Ralf
Published in Cancer gene therapy (01.12.2003)

Get full text

Journal Article

Venous thromboembolic events with chemotherapy plus bevacizumab: A pooled analysis of over 6,000 patients in randomized phase II and III studies

Venous thromboembolic events with chemotherapy plus bevacizumab: A pooled analysis of over 6,000 patients in randomized phase II and III studies

by Cassidy, J., Saltz, L., Van Cutsem, E., Hedrick, E. E., Lasserre, S., Sirzen, F., Rohr, U. P., Hurwitz, H.
Published in Journal of clinical oncology (20.05.2010)

Get full text

Journal Article

Safety of bevacizumab in patients with metastases to the central nervous system

Safety of bevacizumab in patients with metastases to the central nervous system

by Rohr, U. P., Augustus, S., Lasserre, S. F., Compton, P., Huang, J.
Published in Journal of clinical oncology (20.05.2009)

Get full text

Journal Article

Tandem high-dose therapy with autologous stem cell support for small-cell lung cancer (SCLC)

Tandem high-dose therapy with autologous stem cell support for small-cell lung cancer (SCLC)

by Machatschek, J. N., Kobbe, G., Haas, R., Rohr, U. P.
Published in Journal of clinical oncology (20.06.2006)

Get full text

Journal Article

A phase II study for selection of clinical and molecular predictors for survival in patients (pts) with advanced NSCLC treated with erlotinib

A phase II study for selection of clinical and molecular predictors for survival in patients (pts) with advanced NSCLC treated with erlotinib

by Rohr, U. P., Rohrbeck, A., Schwalen, A., Kliszewski, S., Haas, R., Kronenwett, R., Kappes, R., Von Haeseler, A., Rosskopf, M., Meckenstock, G.
Published in Journal of clinical oncology (20.06.2006)

Get full text

Journal Article

Molecular signature of [CD34.sup.+] hematopoietic stem and progenitor cells of patients with CML in chronic phase

Molecular signature of [CD34.sup.+] hematopoietic stem and progenitor cells of patients with CML in chronic phase

by Diaz-Blanco, E, Bruns, I, Neumann, F, Fischer, J.C, Graef, T, Rosskopf, M, Brors, B, Pechtel, S, Bork, S, Koch, A, Baer, A, Rohr, U.-P, Kobbe, G, von Haeseler, A, Gattermann, N, Haas, R, Kronenwett, R
Published in Leukemia (01.03.2007)

Get full text

Journal Article

Molecular signature of CD34 super(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase

Molecular signature of CD34 super(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase

by Diaz-Bianco, E, Bruns, I, Neumann, F, Fischer, J C, Graef, T, Rosskopf, M, Brors, B, Pechtel, S, Bork, S, Koch, A, Baer, A, Rohr, U-P, Kobbe, G, Kronenwett, R
Published in Leukemia (01.03.2007)

Get full text

Journal Article

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

by Steidl, Ulrich, Kronenwett, Ralf, Rohr, Ulrich-Peter, Fenk, Roland, Kliszewski, Slawomir, Maercker, Christian, Neubert, Peter, Aivado, Manuel, Koch, Judith, Modlich, Olga, Bojar, Hans, Gattermann, Norbert, Haas, Rainer
Published in Blood (15.03.2002)

Get full text

Journal Article

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

by Steidl, Ulrich, Bork, Simone, Schaub, Sebastian, Selbach, Oliver, Seres, Janette, Aivado, Manuel, Schroeder, Thomas, Rohr, Ulrich-Peter, Fenk, Roland, Kliszewski, Slawomir, Maercker, Christian, Neubert, Peter, Bornstein, Stefan R., Haas, Helmut L., Kobbe, Guido, Tenen, Daniel G., Haas, Rainer, Kronenwett, Ralf
Published in Blood (01.07.2004)

Get full text

Journal Article

A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma

A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma

by Bruns, Ingmar, Steidl, Ulrich, Kronenwett, Ralf, Fenk, Roland, Graef, Thorsten, Rohr, Ulrich-Peter, Neumann, Frank, Fischer, Johannes, Scheid, Christof, Hübel, Kai, Haas, Rainer, Kobbe, Guido
Published in Transfusion (Philadelphia, Pa.) (01.02.2006)

Get full text

Journal Article